WEST HARRISON, NY--(Marketwired - March 11, 2014) - Fine tuning the crusade by MELA Sciences, Inc. (NASDAQ: MELA) to identify deadly melanoma earlier is featured in the March 10, 2014 issue of Flaherty Financial News Newsletter. It follows up two previous articles written four years ago.
One American an hour is dying from melanoma for which in advanced cases there is no cure. Partly due to the widespread use of tanning beds, more young women are dying of melanoma than any other cancer. Modern imaging technology being pioneered by MELA to replace the less reliable naked eyeball skin lesion inspections performed today can make a difference. Many of the agonizing 8,760 yearly annual deaths from melanoma can be prevented by earlier detection.
New President and CEO Rose A. Crane covered the turnaround changes in MELA Sciences, Inc.'s business model to bring imaging technology to dermatologists, the last large healthcare holdout group. MELA imaging will be a revolution. As opposed to just looking with the naked eye, doctors will be able to understand more of what they are seeing.
The complete article containing our MELA CEO profile presentation snapshot can be found archived on our Flaherty Financial News website at http://www.flahertyfinancialnews.com/.
Direct Server Link To The Report:
Server Link to The Report - With The Modern Social Share Buttons:
About Flaherty Financial News Inc.
Flaherty Financial News Inc. ("FFN") is the publisher of totally-electronic coverage of interesting public companies. FFN was launched in February 2007 by the "legendary financial editor" Bob Flaherty, Editor and Chairman of Flaherty Financial News Inc., and his son Brian, President and Publisher. While previously serving as Chairman and Editor of Equities Magazine for twenty-five years and also Editor-in-Chief of Equities Special Situations, Bob had one of the most consistent and highest ranked long-run performance records measured by Hulbert Financial Digest. He is also an award-winning retired Senior Editor of Forbes Magazine, where he wrote 33 cover stories, two shy of the all-time Forbes record. He was also Chairman of The Over-The-Counter Securities Fund. Bob Flaherty is a Magna Cum Laude graduate of Harvard College in economics and also has an MBA with a Distinction in Finance from Harvard Business School. A former president of the New York Financial Writers' Association, Bob is a co-founder of their annual student scholarship program and their annual award for significant long-term achievement in financial journalism.
This news release contains "forward-looking statements" (as defined in the Private Securities Litigation Reform Act of l995) regarding the snapshot of the MELA Sciences, Inc. CEO company profile presentation and its future business plans. These statements involve known and unknown risks and uncertainties. Such risks and uncertainties may cause actual results and future achievements of all of the companies to be materially different than those implied by these forward-looking statements. Flaherty Financial News Inc. and MELA Sciences, Inc. have and undertake no obligation to provide public updates and revisions to these forward-looking statements to reflect any changes in their expectations of future events.